๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA ยท Real-Time Price ยท USD
13.29
-0.05 (-0.37%)
Nov 20, 2026, 12:35 PM EST - Market open

ADMA Biologics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
519.15510.17426.45258.22154.0880.94
Revenue Growth
6.26%19.63%65.16%67.58%90.36%91.72%
Gross Profit
355.76292.77219.5588.9435.271.17
Operating Income
233.25191.44138.9822.33-39.37-57.57
Net Income
182.41146.93197.67-28.24-65.9-71.65
Earnings Per Share
0.770.600.81-0.13-0.33-0.51
EPS Growth
-9.38%-25.93%----

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
ADMA BioManufacturing
501.57493415.81249.74144.0774.94
Plasma Collection Centers
17.4417.0310.518.339.875.86
License
0.140.140.140.140.140.14
Revenue (Total)
519.15510.17426.45258.22154.0880.94

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
124.5687.63103.1551.3586.5251.09
Total Debt
202.879.8982.12141.42154.44102.92
Net Cash (Debt)
-78.257.7521.03-90.07-67.92-51.83
Net Cash Growth
--63.17%----
Net Cash Per Share
-0.330.030.09-0.40-0.34-0.37

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
140.850.4118.678.8-59.51-112.37
Capital Expenditures
-7.89-22.58-8.23-4.77-13.91-13.51
Free Cash Flow
132.9127.82110.454.03-73.42-125.88
Free Cash Flow Growth
226.36%-74.81%2641.28%---

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
68.53%57.38%51.48%34.45%22.89%1.45%
Operating Margin
44.93%37.52%32.59%8.65%-25.55%-71.13%
Pretax Margin
45.18%35.80%29.48%-10.94%-42.77%-88.52%
Profit Margin
35.14%28.80%46.35%-10.94%-42.77%-88.52%
FCF Margin
25.60%5.45%25.90%1.56%-47.65%-155.52%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
17.2429.5520.51---
Forward PE
16.3122.2425.2836.16--
P/FCF Ratio
22.27156.0436.71253.51--
PS Ratio
5.708.519.513.965.563.41